Chagas myocarditis and syncope

Journal of Cardiovascular Magnetic Resonance

Volumn 7, Issue 4, 2005, Pages 685-688

  Patel, Rajan A G ^a   Dimarco, John P ^a   Akar, Joseph G ^a   Voros, Szilard ^a   Kramer, Christopher M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Chagas disease; MRI; Myocarditis

Indexed keywords

ACUTE DISEASE; ADULT; ARTICLE; CASE REPORT; CHAGAS DISEASE; CHRONIC DISEASE; CONTRAST ENHANCEMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART DISEASE; HEART MUSCLE BIOPSY; HUMAN; MALE; MYOCARDITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SYNCOPE; TRYPANOSOMIASIS;

EID: 23844470849     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1081/JCMR-200065627     Document Type: Article

References (20)

1. Kirchhoff LV. American trypanosomiasis (Chagas Disease)-a tropical disease now in the United States. N Engl J Med 1993; 329:639-644.
2. Grant IH, Gold JW, Wittner M, Tanowitz HB, Nathan C, Mayer K, Reich L, Wollner N, Steinherz L, Ghavimi F. Transfusion-associated acute Chagas disease acquired in the United States. Ann Intern Med 1989; 111:849-851.
3. Barreto ACP, Ianni BM. The undetermined form of Chagas' heart disease: concept and forensic implications. Sao Paulo Med J 1995; 113:797.
4. Salles G, Xavier S, Sousa A, Hasslocher-Moreno A, Cardoso C. Prognostic value of QT interval parameters for mortality and risk stratification in Chagas' disease: results of a long term follow-up study. Circulation 2003; 108:305-312.
5. Kirchhoff LV, Gamm AA, Gusmao A, Goldsmith RS, Rezende M, Rassi A, et al. Increased specificity of serodiagnosis of Chagas disease by detection of antibody to the 72- and 90-kilodalton glycoproteins of Trypanosoma cruzi. J Infect Dis 1987; 155:561-564.
6. Hager JM, Rahimtoola SH. Chagas Heart Disease. Curr Probl Cardiol 1995; 20:825-924.
7. Bestetti RB, Dalbo CM, Freitas OC, Teno LA, Castilho OT, Oliviera JS. Non-invasive predictors of mortality for patients with Chagas heart disease-a multivariate stepwise logistic regression study. Cardiology 1994; 84:261-267.
8. de Paola AAV, Melo WDS, Tavora MZP, Martinez EE. Transcoronary chemical ablation of VT in chronic chagasic myocarditis. J Am Coll Cardiol 1992; 20:480.
9. Bestteti RB, Dalbo CM, Arruda CA, Correia Filho D, Freitas OC. Predictors of sudden cardiac death for patients with Chagas disease: a hospital-derived cohort study. Cardiology 1996; 87:481-487.
10. de Paulo AA, Horowitz LN, Miyamoto MH, Pinheiro R, Ferriera DF, Terzian AB, Circenza C, Guiguer N Jr, Andrade JC, Fo EE. Automatic implantable defibrillator with VVI pacemaker in a patient with chronic Chagas myocarditis and total AV block. Am Heart J 1989; 118:415-417.
11. Muratore C, Rabinovich R, Iglesias R, Gonzalez M, Daru V, Liprandi AS. Implantable cardioverter defibrillator in patients with Chagas disease: are they different from patients with coronary disease. Pacing Clin Electrophysiol 1997; 20:194-197.
12. Curiel R, GESICA investigators. Randomized trial of low dose amiodarone in severe congestive heart failure. Lancet 1994; 344:993-998.
13. Bellotti G, Bocchi EA, de Moraes AV, Higuchi ML, Barbero-Marcial M, Sosa E, Esteves-Filho A, Kalil R, Weiss R, Jatene A, Pileggi F. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas disease. Am Heart J 1996; 131:301-307.
14. Rossi MA, Bestetti RB. The challenge of chagasic cardiomyopathy: the pathologic role of autonomic abnormalities, autoimmune mechanisms and microvascular changes, and therapeutic implications. Cardiology 1995; 86:1.
15. Soares Barreto-Filho JA, Consolim-Colombo FM, Lopes Ferreira H, Sobrinho Martins CR, Guerra-Riccio GM, Krieger EM. Dysregulation of peripheral and central chemoreflex responses in Chagas' heart disease patients without heart failure. Circulation 2001; 104:1792-1798.
16. Jelicks LA, Chandra M, Shtutin V, Petkova SB, Tang B, Christ GJ, Factor SM, Wittner M, Huang H, Douglas SA, Weiss LM, Orleans-Juste PD, Shirani J, Tanowitz HB. Phosphoramidon treatment improves the consequences of chagasic heart disease in mice. Clin Sci 2002; 103:2678-2718.
17. Jelicks LA, Shirani J, Wittner M, Chandra M, Weiss LM, Factor SM, Bekirov I, Braunstein VL, Chan J, Huang H, Tanowitz HB. Application of cardiac gated magnetic resonance imaging in murine Chagas' disease. Am J Trop Med Hyg 1999; 61:207-214.
18. Kalil R, Bocchi EA, Ferrerira BM, de Lourdes Higuchi M, Lopes NH, Magalhaes AC, Mady C, Pereira Barretto AC, Albuquerque CP, Bellotti G. Magnetic resonance imaging in chronic Chagas cardiopathy. Correlation with endomyocardial biopsy findings. Arq Bras Cardiol 1995; 65:413-416.
19. Bocchi EA, Kalil R, Bacal F, de Lourdes Higuchi M, Meneghetti C, Magalhaes A, Belotti G, Ramires JA. Magnetic resonace imaging in chronic Chagas' disease: correlation with endomyocardial biopy findings and gallium 67 cardiac uptake. Echocardiography 1998; 15:279-288.
20. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, Fritz P, Klingel K, Kandolf R, Sechtem U. Cardiovascular magnetic resonace assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004; 109:1250-1258.